E-LIB Suche - Ergebnisse für: Hasebe, Chitomi - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Necessity for surveillance for hepatocellualr carcinoma in ..:

Ishido, Shun ; Tamaki, Nobuharu ; Kurosaki, Masayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290273/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Hepatocellular Carcinoma Risk Assessment for Patients With ..:

Tamaki, Nobuharu ; Kurosaki, Masayuki ; Yasui, Yutaka...
qt3q54824m. , 2022

Link: https://escholarship.org..

3

Real-World Data on Ramucirumab Therapy including Patients W..:

Yasui, Yutaka ; Kurosaki, Masayuki ; Tsuchiya, Kaoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221496/. , 2022

Link: http://www.ncbi.nlm.nih...

4

General evaluation score for predicting the development of ..:

Tada, Toshifumi ; Kurosaki, Masayuki ; Tamaki, Nobuharu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260214/. , 2022

Link: http://www.ncbi.nlm.nih...

5

Change in Fibrosis 4 Index as Predictor of High Risk of Inc..:

Tamaki, Nobuharu ; Kurosaki, Masayuki ; Yasui, Yutaka...
qt5hv334rh. , 2021

Link: https://escholarship.org..

6

Hepatocellular Carcinoma Risk Assessment for Patients With ..:

Tamaki, Nobuharu ; Kurosaki, Masayuki ; Yasui, Yutaka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870028/. , 2021

Link: http://www.ncbi.nlm.nih...

7

The Real-World Data in Japanese Patients with Unresectable ..:

Tsuchiya, Kaoru ; Kurosaki, Masayuki ; Sakamoto, Azusa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198233/. , 2021

Link: http://www.ncbi.nlm.nih...

8

Features of resistance-associated substitutions after failu..:

Itakura, Jun ; Kurosaki, Masayuki ; Kakizaki, Satoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424232/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Detectable HBV DNA during nucleos(t)ide analogues stratifie..:

Kaneko, Shun ; Kurosaki, Masayuki ; Joko, Kouji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400741/. , 2020

Link: http://www.ncbi.nlm.nih...

10

Real‐world efficacy of elbasvir and grazoprevir for hepatit..:

Mashiba, Toshie ; Joko, Kouji ; Kurosaki, Masayuki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899599/. , 2019

Link: http://www.ncbi.nlm.nih...

11

Necessity for surveillance for hepatocellualr carcinoma in ..:

Shun Ishido ; Nobuharu Tamaki ; Masayuki Kurosaki...
https://doi.org/10.1002/jgh3.12914. , 2023

Link: https://doi.org/10.1002/..

12

Hepatocellular Carcinoma Risk Assessment for Patients With ..:

Nobuharu Tamaki ; Masayuki Kurosaki ; Yutaka Yasui...
https://doi.org/10.1002/hep4.1833. , 2022

Link: https://doi.org/10.1002/..

13

A validation study of after direct‐acting antivirals recomm..:

Toshifumi Tada ; Masayuki Kurosaki ; Nobuharu Tamaki...
https://doi.org/10.1002/jgh3.12690. , 2022

Link: https://doi.org/10.1002/..

14

Real-World Data on Ramucirumab Therapy including Patients W..:

Yutaka Yasui ; Masayuki Kurosaki ; Kaoru Tsuchiya...
https://www.mdpi.com/2072-6694/14/12/2975. , 2022

Link: https://doi.org/10.3390/..

15

General evaluation score for predicting the development of ..:

Toshifumi Tada ; Masayuki Kurosaki ; Nobuharu Tamaki...
https://doi.org/10.1002/jgh3.12778. , 2022

Link: https://doi.org/10.1002/..

1-15